Zai Lab is an innovative biopharmaceutical company based in Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.
Since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates.
We see ourselves as the trusted partner of choice for global biopharmaceutical companies seeking to access the Chinese market. Leveraging our team’s extensive global drug development expertise, combined with our demonstrated understanding of the pharmaceutical industry, the increasingly favorable clinical and regulatory environment in China and our in-house manufacturing capabilities, we plan to continue to secure relationships with global pharmaceutical companies to further expand our pipeline and foster innovation in China.
Our team is passionate about bringing transformative new medicines to patients. Our vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing our partner’s and our own products in China and around the world. To that end, we have built manufacturing capabilities to support the clinical and commercial production of our drug candidates in China, and we expect to have further clinical production capabilities in the near future. Our team is planning to establish a specialized commercial team to support marketing of our products in China and beyond, and we are expanding our discovery efforts both internally and through collaborations with leading academic institutions.
Zai Lab is headquartered in Shanghai and has an office in Beijing, R&D center in Shanghai, manufacturing facilities at the Suzhou BioBay China Industry Park and a satellite office in US.